Literature DB >> 15742811

Pseudolaric acid B induces apoptosis through p53 and Bax/Bcl-2 pathways in human melanoma A375-S2 cells.

Xian-Feng Gong1, Min-Wei Wang, Shin-Ichi Tashiro, Satoshi Onodera, Takashi Ikejima.   

Abstract

Pseudolaric acid B is a major compound found in the bark of Pseudolarix kaempferi Gordon. In our study, pseudolaric acid B inhibited growth of human melanoma cells, A375-S2 in a time- and dose-dependent manner. A375-S2 cells treated with pseudolaric acid B showed typical characteristics of apoptosis including morphologic changes, DNA fragmentation, sub-diploid peak in flow cytometry, cleavage of poly-ADP ribose polymerase (PARP) and degradation of inhibitor of caspase-activated DNase (ICAD). P53 protein expression was upregulated while cells were arrested at the G2/M phase of the cell cycle. There was a decrease in the expression of anti-apoptotic Bcl-2 and Bcl-xL proteins, whereas pro-apoptotic Bax was increased. The two classical caspase substrates, PARP and ICAD, were both decreased in a time-dependent manner, indicating the activation of downstream caspases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742811     DOI: 10.1007/bf02975138

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  10 in total

1.  Effect of pseudolaric acid B on gastric cancer cells: inhibition of proliferation and induction of apoptosis.

Authors:  Ke-Shen Li; Xue-Feng Gu; Ping Li; Yong Zhang; Ya-Shuang Zhao; Zhen-Jiang Yao; Nai-Qiang Qu; Bin-You Wang
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B.

Authors:  Guoyi Ma; Li Chong; Xing-Cong Li; Ikhlas A Khan; Larry A Walker; Shabana I Khan
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-07       Impact factor: 4.553

3.  Tetrazolium violet induces G0/G1 arrest and apoptosis in brain tumor cells.

Authors:  Yunfeng Zhao; Nan Zhang; Qingzhong Kong
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

4.  Total synthesis of (-)-pseudolaric acid B.

Authors:  Barry M Trost; Jerome Waser; Arndt Meyer
Journal:  J Am Chem Soc       Date:  2008-12-03       Impact factor: 15.419

5.  Activation of p53 contributes to pseudolaric acid B-induced senescence in human lung cancer cells in vitro.

Authors:  Guo-Dong Yao; Jing Yang; Qiang Li; Ye Zhang; Min Qi; Si-Miao Fan; Toshihiko Hayashi; Shin-Ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Acta Pharmacol Sin       Date:  2016-04-04       Impact factor: 6.150

6.  Induction of G2/M arrest by pseudolaric acid B is mediated by activation of the ATM signaling pathway.

Authors:  Ai-guo Meng; Ling-ling Jiang
Journal:  Acta Pharmacol Sin       Date:  2009-03-23       Impact factor: 6.150

7.  Pseudolaric acid B inhibits proliferation in SW579 human thyroid squamous cell carcinoma.

Authors:  Jinghua Yu; Peiyou Ren; Ting Zhong; Yalin Wang; Minghui Yan; Bianbian Xue; Rui Li; Chunyan Dai; Chunyu Liu; Guang Chen; Xiao-Fang Yu
Journal:  Mol Med Rep       Date:  2015-10-05       Impact factor: 2.952

8.  Pseudolaric acid B induced cell cycle arrest, autophagy and senescence in murine fibrosarcoma l929 cell.

Authors:  Jing hua Yu; Chun yu Liu; Gui bin Zheng; Li Ying Zhang; Ming hui Yan; Wen yan Zhang; Xian ying Meng; Xiao fang Yu
Journal:  Int J Med Sci       Date:  2013-04-09       Impact factor: 3.738

9.  Pseudolaric acid B induced autophagy, but not apoptosis, in MRC5 human fibroblast cells.

Authors:  Yue Wang; Hongmei Gao; Ting Wu; Zengyan Wang; Fengmei Song; Antian Chen; Jing Zhang; Wenyan Zhang; Hui Zhang; Jinghua Yu
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

10.  Functional and morphological evolution in gymnosperms: A portrait of implicated gene families.

Authors:  Amanda R De La Torre; Anthony Piot; Bobin Liu; Benjamin Wilhite; Matthew Weiss; Ilga Porth
Journal:  Evol Appl       Date:  2019-07-21       Impact factor: 5.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.